A multicohort trial of the safety and efficacy of the PD-1 inhibitor MK-3475 in patients with hematologic malignancies.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Guillermo Garcia-Manero, Giovanni Martinelli, Joshua F. Zeidner, David Avigan, Kenneth Carl Anderson, Vincent Ribrag, Craig Moskowitz, Pier Luigi Zinzani, Dianna Wu, Kenneth Emancipator, Marisa Dolled-Filhart, Christine Gause, Holly Brown, Ryan D. Geschwindt, Robert Iannone, Shelonitda Rose, Phillippe Armand
Institutions: The University of Texas MD Anderson Cancer Center, University of Bologna, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2908362803